Facebook Pixel Reshaping health behaviours | Bio Spectrum - Business - Read this story on Magzter.com
Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

Reshaping health behaviours

Bio Spectrum

|

July 2020

In the past three months, healthcare practices have advanced by several years. The year 2020 will be remembered as the year that reshaped health behaviours through accelerated use of digital technologies.

Reshaping health behaviours

It takes 21 days for any habit to change. COVID-19 has given us more time than that. The pandemic made us pause literally, reset and change; for better. They say, sometimes things have to go wrong to go right. COVID-19 pandemic posed several challenges in every aspect of life. Had anyone asked us a hypothetical question about eventualities of the entire world going under lockdown, we would have stayed dumbstruck. Yet here we are; not only coping but also finding better ways of doing various activities.

E-consultations

We would have never thought that we could consult a doctor without travelling all the way to his office. In the past three months, patients are interacting with their doctors on various online platforms. They are using telephone, WhatsApp, and mobile platforms such as Practo, Lybrate, Cure Fit and Portea to consult doctors.

E-consultations provide a win-win situation for patients, doctors and governments. Eighteen years back telemedicine society of India was formed. It is estimated that telemedicine can save upto $4 billion per year for India. Yet the penetration of telemedicine was limited. Pandemic has proven that telemedicine is not only cheaper but also more effective for rural and urban India.

Time is money and more so for a healthcare practitioner. Typically, doctors see patients at multiple locations, clinics and hospitals. Often, the doctor’s time is wasted in commuting between places. Telemedicine saves doctor’s time in a meaningful manner.

MORE STORIES FROM Bio Spectrum

Bio Spectrum

Bio Spectrum

Can India's CDMOS Lead the Next Biopharma Wave?

India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).

time to read

8 mins

March 2026

Bio Spectrum

Bio Spectrum

Telangana turns catalyst for innovation

Telangana is at a pivotal moment in its journey as a global life sciences hub.

time to read

6 mins

March 2026

Bio Spectrum

Bio Spectrum

Is AI the New Weapon in the Fight to End TB?

A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).

time to read

2 mins

March 2026

Bio Spectrum

Bio Spectrum

ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India

US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy

Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"

Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer

Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Haleon ropes in Kedar Lele as President for India Subcontinent

Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Centre revises Startup Recognition Framework to strengthen Startup India Action Plan

The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"

In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.

time to read

5 mins

March 2026

Translate

Share

-
+

Change font size